Protective Effects of Plant-Derived Compounds Against Traumatic Brain Injury Publisher Pubmed



Khayatan D¹ ; Razavi SM¹ ; Arab ZN¹ ; Khanahmadi M¹ ; Samanian A⁴ ; Momtaz S^{3, 5, 6} ; Sukhorukov VN^{7, 8} ; Jamialahmadi T^{9, 10} ; Abdolghaffari AH¹ ; Barreto GE¹¹ ; Sahebkar A^{9, 12, 13} Show Affiliations
Source: Molecular Neurobiology Published:2024

Abstract

Inflammation in the nervous system is one of the key features of many neurodegenerative diseases. It is increasingly being identified as a critical pathophysiological primitive mechanism associated with chronic neurodegenerative diseases following traumatic brain injury (TBI). Phytochemicals have a wide range of clinical properties due to their antioxidant and anti-inflammatory effects. Currently, there are few drugs available for the treatment of neurodegenerative diseases other than symptomatic relief. Numerous studies have shown that plant-derived compounds, in particular polyphenols, protect against various neurodegenerative diseases and are safe for consumption. Polyphenols exert protective effects on TBI via restoration of nuclear factor kappa B (NF-κB), toll-like receptor-4 (TLR4), and Nod-like receptor family proteins (NLRPs) pathways. In addition, these phytochemicals and their derivatives upregulate the phosphatidylinositol-3-Kinase/Protein Kinase B (PI3K/AKT) and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways, which have critical functions in modulating TBI symptoms. There is supporting evidence that medicinal plants and phytochemicals are protective in different TBI models, though future clinical trials are needed to clarify the precise mechanisms and functions of different polyphenolic compounds in TBI. © The Author(s) 2024.